Roopa Industries Ltd

Roopa Industries has announced its financial results for the quarter ending December 2024, revealing net sales of Rs 30.73 crore, a 21.2% increase from the previous year. The company also reported a profit after tax of Rs 0.76 crore and earnings per share of Rs 0.97, both at five-quarter highs.

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation amid positive financial results for the quarter ending September 2024. The company reported significant net sales growth and a profit after tax, although it faces challenges related to long-term financial metrics and high debt levels.

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently adjusted its evaluation following a positive second quarter performance, reporting net sales of Rs 82.20 crore and a profit after tax of Rs 1.31 crore. However, challenges in long-term fundamentals and debt servicing persist.

Roopa Industries, a microcap pharmaceutical company, has been making headlines in the stock market with its stock price reaching a 52-week high on October 23, 2024. The stock has shown a 1.38% increase from its high and has outperformed its sector by 6.07%. With a 'Hold' rating and positive trend, Roopa Industries is a company to watch out for.

Roopa Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on October 23, 2024. It has outperformed the sector by 6.07% and has been on a consecutive gain for the last 3 days, with a 23.88% increase. The stock is trading higher than its moving averages and has shown a remarkable 130.39% performance in the last year compared to the Sensex.

Roopa Industries, a microcap pharmaceutical company, has reached a new milestone as its stock price hit a 52-week high on October 22, 2024. The stock has consistently outperformed the sector and has seen a 98.73% increase in the past year, showcasing its strong performance and potential for growth in the pharmaceutical industry.

Roopa Industries, a microcap pharmaceutical company, has reached an all-time high share price of Rs.96 on October 22, 2024. The stock has outperformed the sector by 3.56% and gained 9.1% in the last two days. It is currently trading above its moving averages and has shown a 1-year performance of 95.88%, making it a promising investment option.

Roopa Industries, a microcap pharmaceutical company, saw its stock price reach a 52-week high of Rs.96 on October 21, 2024. The company's stock has been rated as 'Hold' by MarketsMOJO and is currently trading higher than its moving averages. With a remarkable growth of 92.82% in the past year, Roopa Industries shows potential for growth in the pharmaceutical industry.

Roopa Industries, a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching an all-time high of Rs.94.5 on October 21, 2024. According to MarketsMOJO, the current stock call for Roopa Industries is 'Hold', and the company has outperformed its sector by 3.37% today. With a positive trend and strong performance in the past year, Roopa Industries is gaining attention in the microcap market.

Roopa Industries, a microcap pharmaceutical company, reached an all-time high on September 12th, 2024, with a stock price of Rs.94. Despite underperforming the sector on that day, the stock has consistently outperformed the Sensex in the past year, showcasing its strong growth potential and positive market sentiment.

Roopa Industries, a microcap pharmaceutical company, has reached a new milestone as its stock price hit a 52-week high on September 11, 2024. With a remarkable 18.64% increase in returns over the past two days, the stock has caught the attention of investors and market analysts. Its strong performance and consistent growth make it a company to watch out for in the pharmaceutical sector.

Roopa Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on September 11th, 2024. The stock has outperformed the sector by 10.64% and has shown consecutive gains for the past 2 days, with a 17.37% increase. It is currently trading above its moving averages, indicating a positive trend. This growth can be attributed to the company's strong presence and consistent delivery of quality products in the pharmaceutical industry.

Roopa Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on September 4th, 2024. The stock has been given a 'Hold' rating by MarketsMOJO and is currently trading above its moving averages, showcasing consistent performance. With a remarkable growth of 74.70% in the past year, Roopa Industries is a company to watch out for in the pharma sector.

Roopa Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on September 3rd, 2024. The stock has been performing well, with a 14.42% increase in returns in the last 3 days and trading higher than its moving averages. With a strong performance in the past year, Roopa Industries shows potential for growth and stability in the market.

Roopa Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on September 2nd, 2024. Despite some volatility, the stock has been performing well, outperforming the sector by 6.42% and showing consecutive gains for the past 2 days. With a strong performance in the past year, Roopa Industries has caught the attention of investors and is a company to watch in the pharmaceutical industry.

Roopa Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on August 26, 2024. With a strong performance and positive outlook in the pharmaceutical industry, the company's stock has outperformed the sector by 0.5% in the past 8 days, resulting in a 25.92% increase in returns for investors.

Roopa Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on August 23, 2024. The stock has outperformed its sector by 1.66% and gained 25.62% in the last 7 days. With a 'Hold' call from MarketsMOJO, the stock is trading higher than its moving averages and has shown an impressive 1-year performance of 89.43%, making it a promising player in the pharma industry.

Roopa Industries, a microcap pharmaceutical company, has reported a positive financial performance for the quarter ending March 2024. The company's net sales have increased by 96.0% compared to the previous four quarters, indicating a strong and consistent growth. MarketsMOJO has given a 'Hold' call for the company's stock, suggesting a steady performance in the near future.

Roopa Industries, a microcap pharmaceutical company, has received a 'Sell' rating from MarketsMOJO due to its weak long-term fundamental strength and high debt levels. Despite a 44.46% return in the past year, the company's profits have only risen by 12.6%, resulting in a PEG ratio of 2.4. Investors should carefully consider these factors before making any investment decisions.